Dr. Sarah Cuschieri graduated as a medical doctor in 2011 and began a full-time academic and research career at the University of Malta in 2013. In 2023, she was appointed as an Adjunct Research Professor in the Department of Epidemiology and Biostatistics at the Schulich School of Medicine & Dentistry, Western University, Canada. She was also elected Vice-President of the Chronic Diseases Section of the European Public Health Association (EUPHA) and, in 2024, joined the Scientific Board of the Joint Action on Cardiovascular Disease and Diabetes (JACRDI).
Dr. Cuschieri holds a postgraduate Diploma and Master’s degree in Diabetes Mellitus Type 2 from Cardiff University, both awarded with distinction, along with Cardiff’s Silver Award of Excellence. In 2019, she completed her Ph.D. on the "Burden of Diabetes Mellitus Type 2 and Dysglycaemia in Malta" and earned a certificate in Public Health Epidemiology from the University of Utrecht. Her achievements include the Academic Leadership Award from Junior Chamber International’s Ten Outstanding Young Persons (TOYP) in 2021, Membership through Distinction with the Faculty of Public Health UK in 2022, and a Fellowship in Higher Education (AdvanceHE) in 2024. In 2024, she also earned a second Ph.D. in Population Health/Public Health from Cardiff University, further solidifying her expertise and contributions to the field.
Her research interests are in population health, especially focusing on non-communicable diseases such as Type 2 diabetes and obesity, multimorbidity, sex differences, COVID-19, Long COVID, and medical education. She has consistently ranked in the top 2% of the world’s most-cited scientists (2020-2023). Dr. Cuschieri has authored four books, including To Do or Not to Do a PhD? and A Roadmap to Successful Scientific Publishing, as well as multiple book chapters. She has also been an invited keynote speaker at both international and local conferences.
Currently, she serves as the principal investigator for Horizon Europe Project RAPIDE (Regular and Unplanned Care Adaptive Dashboard for Cross-Border Emergencies) and is actively involved in several collaborative research projects, particularly in the areas of multimorbidity, small European states, and Long COVID.
